American Association for the Advancement of Science, Science Translational Medicine, 626(14), 2022
DOI: 10.1126/scitranslmed.abf0992
Full text: Unavailable
TRIB3 promotes exclusion of CD8+T cells and enhances immune evasion by inhibiting the STAT1-CXCL10 signaling axis in colorectal cancer.